Effect of DLBS1033 on Functional Outcomes for Patients with Acute Ischemic Stroke: A Randomized Controlled Trial

Table 5

Adverse events.

	No. (%)
	Experimental group	Control group	Total
Hospital discharge
Any adverse event	6 (6.7%)	8 (8.9%)	14 (7.8%)
No adverse event	83 (92.2%)	79 (87.8%)	162 (90%)
Day 30
Any adverse event	2 (2.2%)	3 (3.3%)	5 (5.6%)
No adverse event	74 (82.2%)	69 (76.7%)	143 (79.4%)